as on November 7, 2025 at 10:41 pm IST
Day's Low
Day's High
2.28%
Downside
1.15%
Upside
52 Week's Low
52 Week's High
58.79%
Downside
23.15%
Upside
Check Rigel Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$678.9M
EPS (TTM)
6.1497
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
17.87%
PE Ratio (TTM)
6.97
Industry PE ratio
-2.8140502793296087
PEG Ratio
-0.1
EBITDA
107.0M
Revenue (TTM)
267.9M
Profit Margin
36.51%
Return On Equity TTM
37.61%
Track how Rigel Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Rigel Pharmaceuticals Inc in the last 5 years
Lowest (-180.93x)
December 31, 2020
Industry (-2.81x)
November 7, 2025
Today (6.97x)
November 7, 2025
Highest (19.79x)
September 30, 2024
Today’s Price to Earnings Ratio: 6.97x
Compare market cap, revenue, PE, and other key metrics of Rigel Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $678.9M | 37.86% | 6.97 | 36.51% | |
| BUY | $39.6B | 470.1% | -16.34 | -264.83% | |
| BUY | $57.4B | 236.95% | 1448.53 | 1.36% | |
| BUY | $105.8B | 88.96% | 29.32 | 31.35% | |
| BUY | $67.7B | 11.91% | 15.43 | 32.13% |
The Rigel Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Rigel Pharmaceuticals Inc investment value today
Current value as on today
₹2,35,029
Returns
₹1,35,029
(+135.03%)
Returns from Rigel Pharmaceuticals Inc Stock
₹1,29,922 (+129.92%)
Dollar Returns*
₹5,107 (+5.11%)
Based on 12 analysts
58.33%
Buy
41.67%
Hold
0.00%
Sell
Based on 12 analysts, 58.33% of analysts recommend a 'BUY' rating for Rigel Pharmaceuticals Inc. Average target price of $45.4
Get share price movements and forecasts by analysts on Rigel Pharmaceuticals Inc.
What analysts predicted
21.81%UPSIDE
Target Price
$45.4
Current Price
$35.5
Analyzed by
12 Analysts
Target
$45.40
Rigel Pharmaceuticals Inc target price $45.4, a slight upside of 21.81% compared to current price of $35.5. According to 12 analysts rating.
Search interest for Rigel Pharmaceuticals Inc Stock has increased by 27% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:27% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, RIGL stock has moved up by 14.4%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 921.9% return, outperforming this stock by 537.8%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 159.0% return, outperforming this stock by 25.1%
Profit Down
![]()
Netprofit is down for the last 2 quarters, 59.61M → 27.9M (in $), with an average decrease of 53.2% per quarter
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 101.68M → 69.46M (in $), with an average decrease of 31.7% per quarter
| Organisation | Rigel Pharmaceuticals Inc |
| Headquarters | 611 Gateway Boulevard, South San Francisco, CA, United States, 94080 |
| Industry | Health Technology |
| CEO | Mr. Raul R. Rodriguez |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Joseph Lasaga | Executive VP & Chief Business Officer |
Mr. Tarek Sallam | Vice President of Marketing |
Mr. Raul R. Rodriguez | President, CEO & Director |
Mr. Dean L. Schorno CPA | Executive VP & CFO |
Mr. Raymond J. Furey J.D. | Executive VP, Chief Compliance Officer, General Counsel & Corporate Secretary |
Mr. David A. Santos | Executive VP & Chief Commercial Officer |
Dr. Lisa Rojkjaer M.D. | Executive VP & Chief Medical Officer |
Ms. Julie Patel | Senior VP of Human Resources |
Rigel Pharmaceuticals Inc share price today is $35.5 as on . Rigel Pharmaceuticals Inc share today touched a day high of $35.91 and a low of $34.69.
Rigel Pharmaceuticals Inc share touched a 52 week high of $43.72 on and a 52 week low of $14.63 on . Rigel Pharmaceuticals Inc stock price today i.e. is trending at $35.5,which is 18.80% down from its 52 week high and 142.65% up from its 52 week low.
Rigel Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Rigel Pharmaceuticals Inc (RIGL) shares with as little as ₹88.626 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.26 in Rigel Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Rigel Pharmaceuticals Inc share’s latest price of $35.5 as on November 7, 2025 at 10:41 pm IST, you will get 0.2817 shares of Rigel Pharmaceuticals Inc. Learn more about
fractional shares .
Rigel Pharmaceuticals Inc stock has given 37.86% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?